🇺🇸 FDA
Patent

US 7268136

Compositions useful as inhibitors of protein kinases

granted A61KA61K31/495A61K31/503

Quick answer

US patent 7268136 (Compositions useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K31/495, A61K31/503, A61K31/5377, A61K31/541